Basel, Switzerland

Rudolf Wälchli

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2024

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: The Innovative Mind of Rudolf Wälchli

Introduction

Rudolf Wälchli, based in Basel, Switzerland, is an esteemed inventor in the pharmaceutical field. With a keen focus on innovative compounds and therapeutic applications, he has contributed significantly to the industry, holding two patents to his name.

Latest Patents

Rudolf's latest patents include "Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof." This invention provides a compound of a specific formula or a pharmaceutically acceptable salt thereof. The patent further outlines methods for manufacturing these compounds and explores their therapeutic uses. Additionally, it includes a combination of pharmacologically active agents and a pharmaceutical composition, demonstrating Rudolf's commitment to advancing medical science.

Career Highlights

Currently, Rudolf Wälchli is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to refine his inventive processes and engage in the development of cutting-edge pharmaceutical solutions that address various medical challenges.

Collaborations

Rudolf's innovative efforts are often supported by a talented team, including notable colleagues such as Mallesh Bushaboina and Xin Chen. Collaborations like these highlight the importance of teamwork in fostering creativity and driving forward-thinking solutions in the pharmaceutical domain.

Conclusion

In conclusion, Rudolf Wälchli represents the spirit of innovation in the pharmaceutical industry. His patents reflect a dedication to improving health through advanced medicinal compounds, reinforcing his position as a valuable contributor to modern science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…